Novamab
Shanghai, CN · 7 employees on LinkedIn · 1 known investors
Novamab (上海洛启生物医药) is a clinical-stage biopharmaceutical company developing VHH (nanobody) antibody drugs for respiratory and inflammatory diseases, with pipelines including inhaled, oral, and bi/multi-specific antibody platforms targeting asthma, COPD, and inflammatory bowel disease. Based in Shanghai, its drug candidates address indications such as IL-4Rα, TSLP, and TL1A.
Founders & leadership
YW
Yakun WaninFounder
Investors · 1
In the news
Frequently asked questions
- What does Novamab do?
- Novamab (上海洛启生物医药) is a clinical-stage biopharmaceutical company developing VHH (nanobody) antibody drugs for respiratory and inflammatory diseases, with pipelines including inhaled, oral, and bi/multi-specific antibody platforms targeting asthma, COPD, and inflammatory bowel disease. Based in Shanghai, its drug candidates address indications such as IL-4Rα, TSLP, and TL1A.
- Who founded Novamab?
- Novamab was founded by Yakun Wan.
- Who are Novamab's investors?
- Novamab's investors include Qiming Venture Partners.
- Where is Novamab headquartered?
- Novamab is headquartered in Shanghai, CN.